• LAST PRICE
    0.1823
  • TODAY'S CHANGE (%)
    Trending Down-0.0022 (-1.2087%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.1889 / 0.1845
  • Day Range
    Low 0.1809
    High 0.1889
  • 52 Week Range
    Low 0.1640
    High 0.7464
  • Volume
    119,329
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.1845
TimeVolumeNUMIF
09:32 ET105260.1809
09:33 ET20000.184
09:37 ET3000.1812
10:40 ET5000.1836
10:56 ET220000.1811
11:12 ET5000.186
11:14 ET12000.1837
11:43 ET20000.1815
12:08 ET400000.183285
12:15 ET13000.1815
12:32 ET10000.1866
12:33 ET5000.1814
01:27 ET10000.183
02:02 ET5000.18462
02:09 ET12500.18465
02:12 ET50000.18448
02:23 ET50000.18495
02:36 ET24660.183
02:52 ET9000.1861
03:06 ET5000.1845
03:10 ET16000.1847
03:14 ET20350.183
03:15 ET9000.1861
03:26 ET3100.1833
03:35 ET15000.18184
03:37 ET64170.1814
03:46 ET60000.18228
04:00 ET13100.18227
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNUMIF
Numinus Wellness Inc
62.8M
0.0x
---
As of 2022-12-04

Company Information

Numinus Wellness Inc. is a Canada-based mental health care company advancing treatments and safe, evidence-based psychedelic-assisted therapies. The Company develops psychedelic-centered, therapeutic products and services through its own laboratory and research and development processes, to be delivered through its network of physical locations, digital solutions and partnerships. The Company's segments include Laboratory Operations and Clinic Network. Its clinic network consists of Numinus Health, Mindspace Services (Mindspace) and the Neurology Centre of Toronto (NCT). Its services provided include Ketamine-assisted psychotherapy (KAP) for depression, neurological care and psychotherapy, and counseling by registered psychologists. It develops KAP protocols for other clinical indications, psychedelic neurology programming and therapeutic protocols for other psychedelic substances. Its subsidiaries include Numinus Bioscience Inc., Numinus Health Corp. and Mindspace Services Inc.

Contact Information

Headquarters
33 Water St., Suite 801VANCOUVER, BC, Canada V6B 1R4
Phone
604-329-2079
Fax
604-329-2079

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$62.8M
Revenue (TTM)
$2.8M
Shares Outstanding
256.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.14
Book Value
$0.30
P/E Ratio
0.0x
Price/Sales (TTM)
22.4
Price/Cash Flow (TTM)
---
Operating Margin
-959.37%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.